Skip to main content

JPMORGAN CHASE & CO

Position in PLX — Protalix BioTherapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in PLX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$309,867
+$241,111 QoQ
Shares Held
132,991
+319.7% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 101 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 77% Shared 0% None 23%

Common Shares in PLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. PLX ranks #215 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PLX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $309,867 132,991
2026-03-31 $68,756 31,685
2025-12-31 $55,572 30,874
2025-09-30 $66,578 29,991
2025-06-30 $51,126 34,545
2025-03-31 $4,083 1,595
2024-12-31 $2,998 1,595
2024-09-30 $1,626 1,595
2024-06-30 $1,866 1,595
2024-03-31 $40,971 32,518
2023-12-31 $77,846 43,734
2023-09-30 $72,598 43,734
2023-06-30 $89,520 44,760
2022-06-30 $430 395
2022-03-31 $1,194 1,127
2021-09-30 $7,776 5,847
2021-03-31 $5,766 1,293
2020-12-31 $7,623 2,100
2020-09-30 $8,127 2,100
2020-06-30 $379 100